50 studies found for:    Myasthenia Gravis
Show Display Options
Rank Status Study
21 Active, not recruiting The Evaluation of Belimumab in Myasthenia Gravis (MG)
Condition: Myasthaenia Gravis
Interventions: Biological: Belimumab;   Other: Placebo
22 Completed FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Condition: Myasthenia Gravis
Interventions: Drug: tacrolimus;   Drug: placebo
23 Recruiting Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: HIZENTRA ®
24 Terminated Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: Placebo;   Drug: 250 mg CK-2017357;   Drug: 500 mg CK-2017357
25 Recruiting A Study to Evaluate the Efficacy and Safety of IGIV-C in Symptomatic Subjects With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: IGIV-C;   Drug: Placebo
26 Enrolling by invitation ECU-MG-302: An Extension Trial of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis
Condition: Refractory Generalized Myasthenia Gravis
Intervention: Biological: Eculizumab
27 Recruiting Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis
Interventions: Drug: IGIV-C;   Drug: Placebo
28 Completed A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.
Condition: Myasthenia Gravis Generalised
Interventions: Drug: mycophenolate mofetil [CellCept];   Drug: Placebo
29 Completed A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized
Interventions: Drug: mycophenolate mofetil (CellCept);   Drug: placebo
30 Terminated Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis
Condition: Myasthenia Gravis
Intervention: Drug: immune globulin
31 Recruiting The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy
Condition: Myasthenia Gravis
Interventions: Drug: Azathioprine;   Drug: Leflunomide
32 Recruiting A Study to Assess the Efficacy and Safety of IGIV-C in Patients With Myasthenia Gravis Exacerbations
Condition: Myasthenic Crisis
Intervention: Biological: IGIV-C
33 Recruiting Innovative Measures of Speech and Swallowing Dysfunction in Neurological Disorders
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Myasthenia Gravis;   Myopathies;   Stroke;   Parkinson's Disease
Intervention:
34 Completed Therapeutic Plasma Exchange in MG
Condition: Myasthenia Gravis
Interventions: Other: Skin biopsy;   Other: Single Fiber Electromyography
35 Completed Translation, Cross-cultural Adaptation and Validation of the MGQOL-15-F
Condition: Myasthenia Gravis
Intervention:
36 Terminated Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Condition: Ocular Myasthenia Gravis
Interventions: Drug: Prednisone;   Drug: Placebo;   Drug: Pyridostigmine
37 Recruiting The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
Conditions: Thymectomy;   Myasthenia Gravis
Interventions: Procedure: "3-Hole" subxiphorid and subcostal approach;   Procedure: Trans sternal approach;   Procedure: VATS approach
38 Recruiting Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)
Conditions: Myasthenia Gravis;   Systemic Lupus Erythematosus;   Rheumatoid Arthritis
Intervention: Drug: Bortezomib
39 Unknown  Serum Auto-Antibodies
Conditions: Multiple Sclerosis;   Myasthenia Gravis;   Transverse Myelitis
Intervention: Other: Blood Draw
40 Completed An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Condition: Myasthenia Gravis
Intervention: Drug: tacrolimus

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Indicates status has not been verified in more than two years